Q: Tenaz was a top pick this week on BNN Market Call and Bruce Campbell made some compelling argument. I see three past 5i responses to members questions spaced about a year apart that all seemed generally favourable with the small cap/commodity cyclicality risk noted. Since the last of those comments was about a year ago, can I ask for the annual update? (I note the stock popped about 5% at the time of broadcast). Thanks.
Q: Would you agree that an investor has to buy things that are speculative in order to find multi baggers early on? People who were early to the AI market likely had several go to zero and don't care if they hit on Nvidia as an example. I'm asking because I know that Google is in the Quantum field but should an investor consider a basket of stocks like IONQ, D-Wave, Quantum Emotion and BTQ knowing that some will be worthless and some may sky rocket? If an investor was willing to effectively gamble on $10,000 would you concentrate your bet or spread it around? Lastly, which are your three best bets among those I listed?
Q: Hi, 5i team. What are your thoughts on this company? It has been doing okay lately and I have a relatively small position atm but want to add as I find it compelling. Thoughts?
I continue to struggle with the lack of progress by this company! They’re making all sorts of moves with board members, but no change at the top!! The product is just not selling! Again I ask, is there something about this Product and the Company that long investors are missing? Would appreciate your assessment. Thank You. Stan.
Q: I have self directed RRSP. It is made up of equities and fixed income investments. I have investment in 16 companies of which 10 are in the Income Model Portfolio. My goal for this account is to have safe reliable dividends with moderate capital appreciation. For the past year I have invested all dividends in money market account. The money market account now makes up 8% of my account. I am 66 years old and do not need the dividend income currently but I will be using as part of my regular income in 2 to 4 years. Would you recommend BPF.UN as part of my portfolio?
Q: Kraken reports on Thursday. What are the expectations? What one aspect if positive would really boost the share price and what metric if highly negative would cause price damage? What might one worry about (surprise) in the results.
Q: Can you please comment on E's recent Q and it's future prospects. Jason Donville at DKAM sees it as a potential multibagger and I am wondering if this is one of his rare misses or if he is just a little early.
Q: This stock is up 50% in less than a month and is at a 52 week high it also will be making about 270 million going forward this year. They get to keep 90% of that. My simple math has them at a P/E of 6.4 on a forward basis if they don’t overachieve. There drug is getting traction into the hospitals and with the doctors due to its drug profile.
Aurina has another drug in the pipeline going into phase two that looks good and I hope they go after rheumatoid arthritis. To me everything looks good here. This is my fun stock to stop me from becoming too bored and is finally becoming exciting.
What do you folks think is going on here regarding the big move in the stock price and where it could go. Looks like the existing drug revenue tops out an around 600 million annually.